Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma
- 1 April 1981
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 11 (2) , 140-161
- https://doi.org/10.1016/s0090-8258(81)80003-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Treatment of Advanced Endometrial Carcinoma with TamoxifenNew England Journal of Medicine, 1979
- Progesterone interaction with estrogen and antiestrogen in the rat uterus — receptor effectsSteroids, 1977
- Medroxyprogesterone acetate release from Silastic devices as replacement for local irradiation by radium tubes in preoperative intrauterine packing for endometrial adenocarcinomaGynecologic Oncology, 1977
- TAMOXIFEN AS AN ANTI-TUMOUR AGENT: EFFECT ON OESTROGEN BINDINGJournal of Endocrinology, 1976
- Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorPublished by Elsevier ,1975
- BOOK REVIEWSBJOG: An International Journal of Obstetrics and Gynaecology, 1975
- 3H-OESTRADIOL UPTAKE IN VIVO BY HUMAN UTERINE ENDOMETRIUM: EFFECT OF TAMOXIFEN (I.C.I. 46,474)Clinical Endocrinology, 1974
- THE SELECTIVE UPTAKE OF TAMOXIFEN BY HUMAN UTERINE TISSUEBJOG: An International Journal of Obstetrics and Gynaecology, 1974
- TREATMENT OF MENOMETRORRHAGIA WITH AN ANTI‐OESTROGENClinical Endocrinology, 1972
- Cultures organotypiques de longue durée de deux tumeurs humaines du tube digestifPublished by Elsevier ,1966